NTAGI

The COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) made the recommendation in its 48th…

A separate HPV working group of the National Technical Advisory Group on Immunisation (NTAGI) had examined on 8th June the…

The panel also reviewed data on Covaxin and Corbevax vaccines for the 6-12 age group

The firm has applied for market authorisation after completing the phase-II/III clinical trial with support of the Department of…

According to a source, a meeting of the COVID-19 Working Group was held on 1st April to review the data

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December, 2021, and those…

CDSCO has granted permission to CMC, Vellore, to conduct phase-IV study with Covishield and Covaxin to compare immunogenicity of…

Currently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National COVID-19 Vaccination…

Minister of Health Bharati Pravin Pawar said in Lok Sabha that Covaxin was granted Emergency Use Listing (EUL) by the national…

Responding to a query on the stand of the Indian Government on booster doses, Bharati Pravin Pawar, Union Minister of State for…